Donal O'Connor - Director, Theravance Biopharma, Inc
As of May 20, 2019
Donal O'Connor Net Worth
- Net worth is estimated to be at least $1.17M
- Owns at least 27,571 units of Theravance Biopharma, Inc stock
- Sold an estimated value of $81.83K recently at Theravance Biopharma, Inc
Donal O'Connor Trading
- Largest sale of shares was 4,000 units , worth over $81.83K on May 20, 2019
- In total has made about 1 transaction recently
- Usually trades in May, with the busiest year in 2019
Donal OConnor
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Donal O'Connor Mailing Address
- Mailing address is C/o Perrigo Company Plc 515 Eastern Avenue Allegan MI 49010 MI
Theravance Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Rick E Winningham | 2020 | $1,014,455 | - | $579,646 | - | $579,646 | $6,045 | $6,577,746 |
| Rick E Winningham | 2019 | $983,710 | - | $473,906 | - | $473,906 | $5,496 | $5,932,411 |
| Rick E Winningham | 2018 | $956,600 | $74,767 | $690,154 | - | $690,154 | $5,000 | $2,522,841 |
| Andrew A. Hindman | 2020 | $551,608 | - | $265,278 | - | $265,278 | $5,920 | $2,097,950 |
| Andrew A. Hindman | 2019 | $315,000 | $175,000 | $216,000 | $2,204,956 | $216,000 | - | $3,757,956 |
| Brett Haumann | 2020 | $572,569 | - | $213,589 | - | $213,589 | $53,267 | $2,742,625 |
| Brett Haumann | 2019 | $543,047 | - | $170,000 | - | $170,000 | $42,382 | $2,464,280 |
| Brett Haumann | 2018 | $497,810 | $34,125 | $315,000 | - | $315,000 | $414,300 | $1,517,194 |
| Vijay Sabesan | 2020 | $407,677 | - | $760,326 | - | $760,326 | $6,541 | $3,077,744 |
| Bradford J. Shafer | 2020 | $556,321 | - | $264,999 | - | $264,999 | $6,045 | $2,730,565 |
| Bradford J. Shafer | 2019 | $537,403 | - | $215,611 | - | $215,611 | $6,983 | $2,468,848 |
| Bradford J. Shafer | 2018 | $518,080 | $33,770 | $311,726 | - | $311,726 | $5,000 | $1,124,537 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm
Theravance Biopharma, Inc Insider Trading
- The most recent transaction was 8,829 units sold on March 11, 2021 by Philip Worboys worth over $176.58K
- In the last 6 years, insiders at Theravance Biopharma, Inc sold an estimated value of $50.75M and bought an estimated value of $26.3M
- The most active traders are Bradford Shafer, EVP, Brett Haumann, Chief Medical Officer, and Philip Worboys, SVP
- Insider trading is most common in February, with the busiest year in 2018
Theravance Biopharma, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||